Fetal and neonatal alloimmune thrombocytopenia: a late or missed diagnosis disease in fetal and perinatal health-care settings

References

• Tiller H, Husebekk A, Ahlen MT, et al. 2017. Current perspectives on fetal and neonatal alloimmune thrombocytopenia – increasing clinical concerns and new treatment opportunities. IJWH. 9:223–234.
   PubMed Web of Science ®Google Scholar
• Bussel JB. Alloimmune thrombocytopenia in the fetus and newborn. Semin Thromb Hemost. 2001;27(3):245–252.
   PubMed Web of Science ®Google Scholar
• Winkelhorst D, Murphy MF, Greinacher A, et al. Antenatal management in fetal and neonatal alloimmune thrombocytopenia: a systematic review. Blood. 2017;129(11):1538–1547.
   PubMed Web of Science ®Google Scholar
• Brouk H, Ouela H. Fetal and Neonatal alloimmune thrombocytopenia: advance in laboratory diagnostic and management. Int J Blood Res Dis. 2015;2(1):13.
   Google Scholar
• Delbos F, Bertrand G, Croisille L, et al. Fetal and Neonatal alloimmune thrombocytopenia: predictive factors of intracranial hemorrhage. Transfusion. 2016;56(1):59–66.
   PubMed Web of Science ®Google Scholar
• Peterson JA, McFarland JG, Curtis BR, et al. Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management. Br J Haematol. 2013;161(1):3–14.
   PubMed Web of Science ®Google Scholar
• Winkelhorst D, Kamphuis MM, de Kloet LC, et al. Severe bleeding complications other than intracranial hemorrhage in neonatal alloimmune thrombocytopenia: a case series and review of the literature. Transfusion. 2016;56(5):1230–1235.
   PubMed Web of Science ®Google Scholar
• Klüter H, Fehlau K, Panzer S, et al. Rapid typing for human platelet antigen systems– 1, −2, −3 and −5 by PCR amplification with sequence-specific primers. Vox Sang. 1996;71(2):121–125.
   PubMed Web of Science ®Google Scholar
• Cavanagh G, Dunn AN, Chapman CE, et al. HPA genotyping by PCR sequence-specific priming (PCR-SSP): a streamlined method for rapid routine investigations. Transfus Med. 1997;7(1):41–45.
   PubMed Web of Science ®Google Scholar
• Skogen B, Bellissimo DB, Hessner MJ, et al. Rapid determination of platelet alloantigen genotypes by polymerase chain reaction using allele-specific primers. Transfusion. 1994;34(11):955–960.
   PubMed Web of Science ®Google Scholar
• Schuh AC, Watkins NA, Nguyen Q, et al. A tyrosine703serine polymorphism of CD109 defines the Gov platelet alloantigens. Blood. 2002;99(5):1692–1698.
   PubMed Web of Science ®Google Scholar
• National Institute for Biological Standards and Controls (NIBSC). PCR-SSP protocols for HPA-1 to −5 and −15. Available from: http://www.nibsc.org/asset.ashx?assetid=3e82f838-2fca-412c-ad74-9bb64e3308b7.
   Google Scholar
• Metcalfe P, Minchinton RM, Murphy MF, et al. Use of chloroquine-treated granulocytes and platelets in the diagnosis of immune cytopenias. Vox Sang. 1985;49(5):340–345.
   PubMed Web of Science ®Google Scholar
• Nordhagen R, Flaathen ST. Chloroquine removal of HLA antigens from platelets for the platelet immunofluorescence test. Vox Sang. 1985;48(3):156–159.
   PubMed Web of Science ®Google Scholar
• Jauniaux E, Jurkovic D, Gulbis B, et al. Materno-fetal immunoglobulin transfer and passive immunity during the first trimester of human pregnancy. Hum Reprod. 1995;10(12):3297–3300.
   PubMed Web of Science ®Google Scholar
• Zdravic D, Yougbare I, Vadasz B, et al. Fetal and neonatal alloimmune thrombocytopenia. Semin Fetal Neonat Med. 2016;21(1):19–27.
   PubMed Web of Science ®Google Scholar
• De la Vega Elena CD, Nogués N, Fernández Montoya A, et al. Human platelet-specific antigens frequencies in the Argentinean population. Transfus Med. 2008;18(2):83–90.
   PubMed Web of Science ®Google Scholar
• Santoso S, Wihadmadyatami H, Bakchoul T, et al. Antiendothelial αvβ3 antibodies are a major cause of intracranial bleeding in fetal/neonatal alloimmune thrombocytopenia. Arterioscler Thromb Vasc Biol. 2016;36(8):1517–1524.
   PubMed Web of Science ®Google Scholar
• Wu G-G, Zhou Y, Shen W-D, et al. HPA-3a neonatal alloimmune thrombocytopenia: a case report from China, and HPA-3 allele frequencies in the Guang Xi Zhuang and Han populations. VOXS. 2015;10(2):57–60.
   Google Scholar
• Kjeldsen-Kragh J, Husebekk A, Killie MK, et al. Is it time to include screening for neonatal alloimmune thrombocytopenia in the general antenatal health care programme? Transfus Apher Sci. 2008;38(3):183–188.
   PubMed Web of Science ®Google Scholar
• Skogen B, Killie MK, Kjeldsen-Kragh J, et al. Reconsidering fetal and neonatal alloimmune thrombocytopenia with a focus on screening and prevention. Expert Rev Hematol. 2010;3(5):559–566.
   PubMed Web of Science ®Google Scholar
• Tiller H, Killie MK, Skogen B, et al. Neonatal alloimmune thrombocytopenia in Norway: poor detection rate with nonscreening versus a general screening programme. BJOG. 2009;116(4):594–598.
   PubMed Web of Science ®Google Scholar
• Kaplan C, Morel-Kopp MC, Clemenceau S, et al. Fetal and neonatal alloimmune thrombocytopenia: current trends in diagnosis and therapy. Transfus Med. 1992;2(4):265–271.
   PubMed Web of Science ®Google Scholar
• Rayment R, Birchall J, Yarranton H, et al. Neonatal alloimmune thrombocytopenia. BMJ. 2003;327(7410):331–332.
   PubMed Web of Science ®Google Scholar
• Nomura ML, Couto E, Martinelli BM, et al. Fetal genotyping for platelets antigens: a precise tool for alloimmune thrombocytopenia: case report and literature review. Arch Gynecol Obstet. 2010;282(5):573–575.
   PubMed Web of Science ®Google Scholar
• Peterson JA, Gitter M, Bougie DW, et al. Low-frequency human platelet antigens as triggers for neonatal alloimmune thrombocytopenia. Transfusion. 2014;54(5):1286–1293.
   PubMed Web of Science ®Google Scholar
• Hayashi T, Hirayama F. Advances in alloimmune thrombocytopenia: perspectives on current concepts of human platelet antigens, antibody detection strategies, and genotyping. Blood Transfus. 2015;13(3):380–390.
   PubMed Web of Science ®Google Scholar